Capsida Biotherapeutics Patents – Insights & Stats (Updated 2024)
Capsida Biotherapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 65% patents are active. Australia and Canada is where Capsida Biotherapeutics has filed the maximum number of patents, followed by Japan, United States of America and Europe.